tiprankstipranks
Trending News
More News >
CompuGroup Medical SE (DE:COP)
XETRA:COP
Germany Market

CompuGroup Medical (COP) Stock Forecast & Price Target

Compare
31 Followers
See the Price Targets and Ratings of:

COP Analyst Ratings

Moderate Buy
1Ratings
Moderate Buy
1 Buy
0 Hold
0 Sell
Based on 1 analysts giving stock ratings to
CompuGroup
Medical
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

COP Stock 12 Month Forecast

Average Price Target

€29.00
▲(31.46%Upside)
Based on 1 Wall Street analysts offering 12 month price targets for CompuGroup Medical in the last 3 months. The average price target is €29.00 with a high forecast of €29.00 and a low forecast of €29.00. The average price target represents a 31.46% change from the last price of €22.06.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"12":"€12","21":"€21","30":"€30","16.5":"€16.5","25.5":"€25.5"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":29,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">€29.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":29,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">€29.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":29,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">€29.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[12,16.5,21,25.5,30],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Jul<br/>2024","6":"Oct<br/>2024","9":"Jan<br/>2025","12":"Apr<br/>2025","25":"Apr<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,22.72,23.20307692307692,23.686153846153847,24.16923076923077,24.65230769230769,25.135384615384616,25.61846153846154,26.10153846153846,26.584615384615383,27.067692307692308,27.55076923076923,28.033846153846156,28.516923076923078,{"y":29,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,22.72,23.20307692307692,23.686153846153847,24.16923076923077,24.65230769230769,25.135384615384616,25.61846153846154,26.10153846153846,26.584615384615383,27.067692307692308,27.55076923076923,28.033846153846156,28.516923076923078,{"y":29,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,22.72,23.20307692307692,23.686153846153847,24.16923076923077,24.65230769230769,25.135384615384616,25.61846153846154,26.10153846153846,26.584615384615383,27.067692307692308,27.55076923076923,28.033846153846156,28.516923076923078,{"y":29,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":27.038,"date":1711929600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":27.134,"date":1714521600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":27.7,"date":1717200000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":23.76,"date":1719792000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 17,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":15.8,"date":1722470400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":15.07,"date":1725148800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":14,"date":1727740800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":13.78,"date":1730419200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":15.62,"date":1733011200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":21.76,"date":1735689600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":23.1,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":22.3,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":22.72,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target€29.00Average Price Target€29.00Lowest Price Target€29.00
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
TipRanks Analyst forecast on DE:COP
TipRanks AITipRanks
Not Ranked
TipRanks
€23
Hold
4.26%
Upside
Reiterated
05/09/25
CompuGroup Medical maintains a stable financial position with strong cash flow and operational efficiency, but faces challenges in profitability and leverage management. Technical analysis indicates neutral market momentum, while high valuation metrics suggest potential overvaluation. The attractive dividend yield provides some support, but the overall sentiment remains cautious.
Baader Bank Analyst forecast on DE:COP
Knut WollerBaader Bank
Baader Bank
€29
Buy
31.46%
Upside
Reiterated
04/30/25
Baader Bank Reaffirms Their Buy Rating on CompuGroup Medical (0MSD)
Jefferies Analyst forecast on DE:COP
Fabian PiastaJefferies
Jefferies
€22
Hold
-0.27%
Downside
Reiterated
03/04/25
Cautious Outlook for CompuGroup Medical Amid Declining EBITDA and Strategic Uncertainties
Morgan Stanley Analyst forecast on DE:COP
Laura MetayerMorgan Stanley
Morgan Stanley
€25€22
Hold
-0.27%
Downside
Reiterated
01/14/25
Compugroup medical SE (COP:GR) PT Lowered to EUR22 at Morgan StanleyMorgan Stanley analyst Laura Metayer lowered the price target on Compugroup medical SE (COP:GR) to EUR22.00 (from EUR25.00) while maintaining a Equalweight rating.
Berenberg Bank Analyst forecast on DE:COP
Wolfgang SpechtBerenberg Bank
Berenberg Bank
€21€22
Hold
-0.27%
Downside
Downgraded
12/09/24
CompuGroup Medical (0MSD) was downgraded to a Hold Rating at Berenberg Bank
Kepler Capital  Analyst forecast on DE:COP
Florian TreischKepler Capital
Kepler Capital
€20
Buy
-9.34%
Downside
Reiterated
12/09/24
Kepler Capital Keeps Their Buy Rating on CompuGroup Medical (0MSD)
Warburg Research Analyst forecast on DE:COP
Andreas WolfWarburg Research
Warburg Research
€31€24.5
Buy
11.06%
Upside
Reiterated
12/06/24
Hauck & Aufhaeuser Analyst forecast on DE:COP
Simon KellerHauck & Aufhaeuser
Hauck & Aufhaeuser
€10
Sell
-54.67%
Downside
Downgraded
12/04/24
CompuGroup Medical (0MSD) was downgraded to a Sell Rating at Hauck & Aufhaeuser
Stifel Nicolaus Analyst forecast on DE:COP
Yannik SieringStifel Nicolaus
Stifel Nicolaus
€18
Hold
-18.40%
Downside
Downgraded
11/28/24
CompuGroup Medical Downgraded to Hold: Challenges in Software Sales and Project Execution Limit Recovery Prospects
Deutsche Bank  Analyst forecast on DE:COP
Nicolas HermsDeutsche Bank
Deutsche Bank
€16
Hold
-27.47%
Downside
Reiterated
11/08/24
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
TipRanks Analyst forecast on DE:COP
TipRanks AITipRanks
Not Ranked
TipRanks
€23
Hold
4.26%
Upside
Reiterated
05/09/25
CompuGroup Medical maintains a stable financial position with strong cash flow and operational efficiency, but faces challenges in profitability and leverage management. Technical analysis indicates neutral market momentum, while high valuation metrics suggest potential overvaluation. The attractive dividend yield provides some support, but the overall sentiment remains cautious.
Baader Bank Analyst forecast on DE:COP
Knut WollerBaader Bank
Baader Bank
€29
Buy
31.46%
Upside
Reiterated
04/30/25
Baader Bank Reaffirms Their Buy Rating on CompuGroup Medical (0MSD)
Jefferies Analyst forecast on DE:COP
Fabian PiastaJefferies
Jefferies
€22
Hold
-0.27%
Downside
Reiterated
03/04/25
Cautious Outlook for CompuGroup Medical Amid Declining EBITDA and Strategic Uncertainties
Morgan Stanley Analyst forecast on DE:COP
Laura MetayerMorgan Stanley
Morgan Stanley
€25€22
Hold
-0.27%
Downside
Reiterated
01/14/25
Compugroup medical SE (COP:GR) PT Lowered to EUR22 at Morgan StanleyMorgan Stanley analyst Laura Metayer lowered the price target on Compugroup medical SE (COP:GR) to EUR22.00 (from EUR25.00) while maintaining a Equalweight rating.
Berenberg Bank Analyst forecast on DE:COP
Wolfgang SpechtBerenberg Bank
Berenberg Bank
€21€22
Hold
-0.27%
Downside
Downgraded
12/09/24
CompuGroup Medical (0MSD) was downgraded to a Hold Rating at Berenberg Bank
Kepler Capital  Analyst forecast on DE:COP
Florian TreischKepler Capital
Kepler Capital
€20
Buy
-9.34%
Downside
Reiterated
12/09/24
Kepler Capital Keeps Their Buy Rating on CompuGroup Medical (0MSD)
Warburg Research Analyst forecast on DE:COP
Andreas WolfWarburg Research
Warburg Research
€31€24.5
Buy
11.06%
Upside
Reiterated
12/06/24
Hauck & Aufhaeuser Analyst forecast on DE:COP
Simon KellerHauck & Aufhaeuser
Hauck & Aufhaeuser
€10
Sell
-54.67%
Downside
Downgraded
12/04/24
CompuGroup Medical (0MSD) was downgraded to a Sell Rating at Hauck & Aufhaeuser
Stifel Nicolaus Analyst forecast on DE:COP
Yannik SieringStifel Nicolaus
Stifel Nicolaus
€18
Hold
-18.40%
Downside
Downgraded
11/28/24
CompuGroup Medical Downgraded to Hold: Challenges in Software Sales and Project Execution Limit Recovery Prospects
Deutsche Bank  Analyst forecast on DE:COP
Nicolas HermsDeutsche Bank
Deutsche Bank
€16
Hold
-27.47%
Downside
Reiterated
11/08/24
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering CompuGroup Medical

1 Month
xxx
Success Rate
24/48 ratings generated profit
50%
Average Return
-0.55%
reiterated a xxx
rating last month
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 50.00% of your transactions generating a profit, with an average return of -0.55% per trade.
3 Months
xxx
Success Rate
24/48 ratings generated profit
50%
Average Return
+0.55%
reiterated a xxx
rating last month
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 50.00% of your transactions generating a profit, with an average return of +0.55% per trade.
1 Year
Knut WollerBaader Bank
Success Rate
24/48 ratings generated profit
50%
Average Return
-4.45%
reiterated a buy rating last month
Copying Knut Woller's trades and holding each position for 1 Year would result in 50.00% of your transactions generating a profit, with an average return of -4.45% per trade.
2 Years
xxx
Success Rate
22/48 ratings generated profit
46%
Average Return
-11.76%
reiterated a xxx
rating last month
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 45.83% of your transactions generating a profit, with an average return of -11.76% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

COP Analyst Recommendation Trends

Rating
Dec 24
Jan 25
Feb 25
Mar 25
Apr 25
Strong Buy
4
3
1
0
0
Buy
5
4
4
4
6
Hold
5
7
4
3
1
Sell
1
1
1
0
0
Strong Sell
0
0
0
0
0
total
15
15
10
7
7
In the current month, COP has received 6 Buy Ratings, 1 Hold Ratings, and 0 Sell Ratings. COP average Analyst price target in the past 3 months is 29.00.
Each month's total comprises the sum of three months' worth of ratings.

COP Financial Forecast

COP Earnings Forecast

The previous quarter’s earnings for COP were €0.35.
The previous quarter’s earnings for COP were €0.35.

COP Sales Forecast

Currently, no sales data available.
Currently, no sales data available.

COP Stock Forecast FAQ

What is DE:COP’s average 12-month price target, according to analysts?
Based on analyst ratings, CompuGroup Medical SE’s 12-month average price target is 29.00.
    What is DE:COP’s upside potential, based on the analysts’ average price target?
    CompuGroup Medical SE has 31.46% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is CompuGroup Medical SE a Buy, Sell or Hold?
          CompuGroup Medical SE has a consensus rating of Moderate Buy, which is based on 1 buy ratings, 0 hold ratings and 0 sell ratings.
            What is CompuGroup Medical SE’s share price target?
            The average share price target for CompuGroup Medical SE is 29.00. This is based on 1 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst share price target is €29.00 ,and the lowest forecast is €29.00. The average share price target represents 31.46% Increase from the current price of €22.06.
              What do analysts say about CompuGroup Medical SE?
              CompuGroup Medical SE’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 1 Wall Streets Analysts.
                How can I buy shares of CompuGroup Medical SE?
                To buy shares of DE:COP, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.
                  What am I Missing?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis